Helix Biopharma Corp
F:HBP
Helix Biopharma Corp
F:HBP
Price:
0.55
EUR
0.92%
Market Closed
Market Cap:
€77.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Helix Biopharma Corp
F:HBP
|
CA |
|
Tivoli A/S
F:6YE
|
DK |
|
Euroz Hartleys Group Ltd
F:E7L
|
AU |
|
M
|
MyMD Pharmaceuticals Inc
F:DQS
|
US |
|
I
|
IDH Development SA
F:7E2
|
PL |
|
China Zheshang Bank Co Ltd
HKEX:2016
|
CN |
|
S
|
Synchronoss Technologies Inc
XBER:H6K
|
US |
|
T
|
Tokai Carbon Co Ltd
SWB:7TC
|
JP |
|
W
|
Weir Group PLC
SWB:42W
|
UK |
|
L
|
Learning Technologies Group PLC
F:LTG
|
UK |
|
N
|
NNIT A/S
SWB:5NN
|
DK |
|
M
|
Mynaric AG
XBER:M0YN
|
DE |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of HBP.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HBP
Multiples-Based Value
Base Case
Not Available
